Centauri Therapeutics’ $32 Million Series A Investment

Goodwin advised BIVF, Novo and Evotec on the deal.Boehringer Ingelheim Venture Fund GmbH (“BIVF”), Novo Holdings REPAIR Impact Fund (“Novo”) and Evotec SE (“Evotec”) led the series…